Cargando…
Deficiency of ADAMTS-13 in pediatric patients with severe sepsis and impact on in-hospital mortality
BACKGROUND: The enzyme involved in regulating the size of vWF (von Willebrand factor) in plasma is ADAMTS-13 (A disintegrin and metalloprotease with thrombospondin type-1 motives). Deficient proteolysis of ULvWF (ultra large von Willebrand factor) due to reduced ADAMTS-13 activity results in dissemi...
Autores principales: | Karim, Farheen, Adil, Salman Naseem, Afaq, Bushra, ul Haq, Anwar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637410/ https://www.ncbi.nlm.nih.gov/pubmed/23537039 http://dx.doi.org/10.1186/1471-2431-13-44 |
Ejemplares similares
-
Decreased ADAMTS 13 Activity is Associated With Disease Severity and Outcome in Pediatric Severe Sepsis
por: Lin, Jainn-Jim, et al.
Publicado: (2016) -
ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 Administration Decreases Colitis Severity in Mice
por: Zitomersky, Naamah L., et al.
Publicado: (2017) -
ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis
por: Gerlicz-Kowalczuk, Zofia, et al.
Publicado: (2018) -
Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
por: Ocak, Gurbey, et al.
Publicado: (2021) -
Hereditary ADAMTS 13 deficiency presenting as recurrent acute kidney injury
por: Jamale, T. E., et al.
Publicado: (2012)